CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 12 (Patent Applications = 13)

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 22(Granted Patents)

Company Filing History:

Boehringer Ingelheim Animal Health USA Inc.

patents

4. 1 out of 9

Aventis Agriculture Limited

patents

where one patent can have more than one assignee

Years Active: 2012-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10597364 - Anthelmintic compounds, compositions and method of using thereof (2020-03-24),

2. 10155725 - Anthelmintic compounds and compositions and method of using thereof (2018-12-18),

3. 9776999 - Antiparisitic dihydroazole compounds and compositions comprising same (2017-10-03),

4. 9376434 - Antiparisitic dihydroazole compounds and compositions comprising same (2016-06-28),

5. 9249102 - Anthelmintic compounds and compositions and method of using thereof (2016-02-02),

6. 8980893 - Antiparisitic dihydroazole compounds and compositions comprising same (2015-03-17),

7. 8618126 - Antiparisitic dihydroazole compounds and compositions comprising same (2013-12-31),

8. 8461176 - Enantiomerically enriched aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof (2013-06-11),

9. 8283475 - Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof (2012-10-09),

10. 8088801 - Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof (2012-01-03),

Certainly! Here is the article about inventor Douglas Edward Wilkinson:

Title: Unveiling the Innovations of Douglas Edward Wilkinson

Introduction:

Douglas Edward Wilkinson, a prolific inventor based in Wake Forest, NC (US), has made significant contributions to the field of anthelmintic compounds through his innovative patents. With a total of 10 patents to his name, Wilkinson has demonstrated a profound understanding of pharmaceutical chemistry and drug development.

Latest Patents:

Among his latest patents is the groundbreaking invention of Anthelmintic compounds, compositions, and methods of use. These novel compounds, represented by formula (IA), have the potential to revolutionize the treatment of parasitic infections in both humans and animals. Additionally, Wilkinson's work on anthelmintic compounds represented by formula (I) underscores his commitment to advancing the field of veterinary medicine.

Career Highlights:

Wilkinson's professional journey has been intertwined with esteemed organizations such as Merial Limited and Aventis Agriculture. His tenure at these companies has provided him with the platform to translate his scientific expertise into tangible innovations that have garnered recognition within the pharmaceutical industry.

Collaborations:

Throughout his career, Wilkinson has collaborated with esteemed colleagues such as Hyoung Ik Lee and Loic Patrick Le Hir de Fallois. These collaborations have not only enriched his research endeavors but have also fostered a culture of knowledge exchange and innovation within the scientific community.

Conclusion:

In conclusion, Douglas Edward Wilkinson stands as a visionary inventor whose contributions have left an indelible mark on the field of pharmaceuticals. His relentless pursuit of scientific excellence and commitment to developing novel solutions underscore the importance of innovation in addressing critical healthcare challenges. Wilkinson's legacy as a pioneering inventor continues to inspire future generations in the realm of anthelmintic research.

If you need more information or have any specific questions about Douglas Edward Wilkinson, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.